Navigation Links
Medivation Plans to Initiate Pivotal Confirmatory Phase 3 Trial of Dimebon(TM) for Alzheimer's Disease in Second Quarter of 2008
Date:1/28/2008

- Conference Call Today at 4:30 p.m. Eastern Time -

SAN FRANCISCO, Jan. 28 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that, based on its end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA), the Company plans to begin a pivotal confirmatory Phase 3 trial of Dimebon(TM) for mild-to-moderate Alzheimer's Disease in the second quarter of 2008.

The FDA informed Medivation that the company's previously completed trial conducted in Russia can be used as one of the two pivotal studies required to support the approval of Dimebon to treat mild-to-moderate Alzheimer's disease, as long as a significant proportion of the sites in the confirmatory Phase 3 trial are located in the United States.

"We are now a Phase 3 company with clear regulatory guidance on the pivotal trials required to seek marketing approval for Dimebon in the United States," said David T. Hung, M.D., president and chief executive officer of Medivation. "This is a significant step forward for Medivation, and validates our strategy to advance Dimebon directly into a pivotal Phase 3 trial."

The Phase 3 clinical trial will enroll approximately 525 patients with mild-to-moderate Alzheimer's disease at sites in the United States, Europe and South America. Patients will be randomized to one of three treatment groups: Dimebon 20 mg three times per day (TID); Dimebon 5 mg TID; and placebo. Patients will be treated for six months and may not be taking any other Alzheimer's disease drugs. The primary endpoints are the Alzheimer's Disease Assessment Scale - cognitive subscale (ADAS-cog) and the Clinician's Interview-Based Impression of Change plus caregiver interview (CIBIC-plus).

In the previously com
'/>"/>

SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Medivation to Announce Early Positive Data from Phase 1-2 Hormone Refractory Prostate Cancer Trial and Host Conference Call and Webcast on Monday, November 5, 2007
2. Health Plans Increase Use of Health Incentives
3. Area Health Care Providers Announce Plans to Integrate Services
4. EDAP Launches Enhanced Communication Plans at SIU Paris Congress
5. National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline
6. Precedent Launches Revolutionary Individual Health Insurance Plans in Texas
7. AMERIGROUP Contracts with Federal Government to Offer Medicare Advantage Health Plans in Seven States
8. CEO Addresses Tennessee Business Leaders About Developing Pandemic and Business Continuity Plans
9. Delta Dental Plans Association Forms National Scientific Advisory Committee
10. Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas
11. Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Nike Swim Camps offer outstanding coaching by ... to stimulate a love of swimming in a positive ... the opportunity to train with some of the most ... President of US Sports Camps. “Our program directors provide ... confidence and improve their technique.” , Nike Swim Camp ...
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... therapeutics market is driven by the increasing incidence of ... encouraging pipeline of late stage drugs. The unmet medical ... fore the untapped potential in the market. Presently, there ... drugs that overcome the limitations of current generation drugs. ...
(Date:3/4/2015)... Ohio (PRWEB) March 04, 2015 Nitrosigine®, ... an ingredient in premium sports nutrition products, is hosting ... Trainer booth in the Terrace Ballroom at The Arnold ... from March 5, 2015 to March 8, 2015. ... silicate with FDA New Dietary Ingredient notification status; now ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the appearance of the skin and body, are witnessing ... therapeutic agents to achieve the desired product properties and ... obsessed with physical beauty, youth, and achievement. Demand for ... sales of cosmetics. Growth in the market is driven ...
(Date:3/4/2015)... The report “Vasculitis – Pipeline Review, ... for Vasculitis. Vasculitis is a disease that features tenderness ... diseases is not known. Vasculitis can affect any body ... Symptoms can include fever, weight loss, tiredness, aches, pains, ... a limb. Vasculitis is treatable, but it is not ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and Nike Swim Camps Announce the 2015 Swim Camps Lineup 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Incidence of CNS Disorders & a Promising Global Drug Pipeline Drive the CNS Therapeutics Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 2Health News:Nitrosigine® Challenges Fitness Enthusiasts at The Arnold to Get Pumped 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Rising Demand for Anti-Aging & Skincare Cosmeceuticals to Drive the Global Cosmetic Chemicals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 2Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 3Health News:Vasculitis Therapeutics Pipeline H1 2015 Review Report Available at RnRMarketResearch.com 4
... University of Utah researchers in the development and testing of ... would transmit the nerve impulses from nerves in the residual ... then to the bionic arm. This will facilitate the person ... ,Sensors placed in the artificial arm will be designed ...
... ocean currents in climate change and the story behind Antarctica’s ... to be holding the clue. ,An element pretty ... teeth has offered a clue to the University of Florida ... Atlantic and Pacific might have opened up. This has happened ...
... Administration is being prompted by the Drug Manufacturer, Wyeth ... hormone drugs to treat menopause.// The drugs are made ... approved. ,Following Wyeth's recommendation to the FDA, the ... on these custom-made treatments, and have requested the agency ...
... Functional and structural difference in the brain can explain ... in unique ways to the effects// of certain pain-relief ... Georgia State University and the Atlanta-based Center for Behavioral ... conducted on rat brains, the results highlight that similar ...
... a report by the Food and Agriculture Organisation (FAO) of ... animal species said that domestic and wild birds spread the ... accumulated since the start of the avian influenza crisis (the ... in the transmission of the virus in the natural setting. ...
... and as a clean up drive legalisation of drugs is ... free drugs to addicts// to help clean up the Downtown ... Sam Sullivan a donation by an anonymous donor of $500,000 ... ,The reason and goal behind this whole exercise would be ...
Cached Medicine News:Health News:Gender Difference In Pain Experience Explained By Brain Diversity 2
(Date:3/4/2015)... 4, 2015   Symbiomix Therapeutics , a ... for serious women,s health infections, today announced results ... its lead product candidate, SYM-1219, was safe and ... that contraceptive efficacy for birth control pills would ... These results will be presented on March 6 ...
(Date:3/3/2015)... 2015  The packaging industry plays a major ... provides containment and drug safety but also ensures ... patent loss delivers more generics into the market, ... turn encouraging low-cost innovation in emerging markets. The ... the pharmaceutical packaging industry towards low-cost, sustainable and ...
(Date:3/3/2015)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical solutions ... at the 27 th Annual ROTH Conference, which is ... California from March 8 to March 11. ... , will be presenting on Monday, March 9 at 12:00 ... , the company,s Vice President of Finance and Chief Accounting ...
Breaking Medicine Technology:Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 2Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 3Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 4Symbiomix Therapeutics Studies Show Drug Candidate for Women's Health Infections is Safe and Well-Tolerated 5Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 2Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 3Customization is the New Formula in Global Pharmaceutical Packaging, Finds Frost & Sullivan 4Vermillion To Present at 27th Annual ROTH Conference on March 9 2
... 8, 2010 George Products Company, Inc. has announced ... of its OASIS Inspection Systems. Florida ... southeast Florida. OASIS Inspection Systems is a line of ... to quality control departments across the United States. Tim ...
... 1st to the 3rd of March 2011, vaccine leaders ... World Summit in New Delhi. The event will be ... Vaccine Manufacturers Network). Participants will be discussing ... pandemic surveillance programs, low cost and fast vaccine manufacturing ...
Cached Medicine Technology:Florida Metrology To Distribute OASIS Inspection Systems 2World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: